LYMErix

LYMErix

Public health A Lyme vaccine comprised of lipidated recombinant OspA–outer surface protein A of Borrelia burgdorferi.
Mentioned in ?
References in periodicals archive ?
Lymerix, developed to prevent Lyme disease, is the only vaccine ever licensed in the United States to prevent a tickborne disease in humans, but it was removed from the market during 2003 amidst poor sales and unsubstantiated reports of increased adverse events (16,17).
Steere, then chief of rheumatology and immunology at Tufts School of Medicine, led the development of Lymerix, which proved 78 percent effective but had questionable long-term effects.
Antibiotics are effective during early stages of the disease, and a vaccine called LYMErix is now available.
Lackluster demand has forced GlaxoSmithKline, maker of LYMErix, to pull the Lyme disease vaccine off the market.
The company says the test has near Western blot accuracy in an ELISA, has no reactivity with Lymerix Lyme vaccine sera, is more sensitive in detection of antibodies in early and late Lyme disease than other kits, and eliminates the majority of other ELISA's false positives at the screening step.
Given as three injections over a year's time, LYMErix is 76 percent effective, and minimal side effects have been reported.
SmithKline Beecham now offers the LYMErix vaccine, which may be worth looking into if you spend a lot of time outdoors.
The point Shoemaker made was that among patients who wanted the Lymerix vaccine following treatment with antibiotics for Lyme disease, there were many who had persistent symptoms attributed, perhaps inappropriately, to other illnesses.
The Food and Drug Administration has approved an enzyme-linked immunosorbent assay for Lyme disease antibodies that does not yield false-positive results in patients who have been vaccinated with the Lymerix vaccine.
Claritin Allergy -- Procrit Anemia -- Tamiflu Flu -- Avandia Diabetes -- Prilosec Heartburn -- Allegra Allergy -- Glucovance Diabetes -- Lymerix Lyme Disease -- Xenical Fat Blocker -- Patanol Allergy
Unfortunately, the only commercially available vaccine, Lymerix, has been discontinued by the manufacturer, and little progress is reported on development of alternative vaccines.